delzicolhcp.com - Pharmaceutical Research & Development | AbbVie

Description: AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives

ulcerative colitis (143) prescribing information (10) delzicol (9) mildly to moderately active ulcerative colitis (9) delzicol savings card (3) delzicol copay card request delzicol samples delzicol patient brochure oral aminosalicylates

Example domain paragraphs

DELZICOL delayed-release capsules are indicated for 1 :

Adults: The recommended dosage is two DELZICOL 400 mg capsules three times daily (total daily dose of 2.4 g/d), with or without food, for a duration of 6 weeks

Pediatric patients 5 years of age and older: Total daily dose is weight-based up to a maximum of 2.4 g/d, with or without food, divided into two daily doses for a duration of 6 weeks